Cite

HARVARD Citation

    Vanover, K. et al. (n.d.). 30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study. CNS spectrums. pp. 190-191. [Online]. 
  
Back to record